Pharmaceutical Companies Third-Quarter Profits News
Pharmaceutical Companies
> Pharmaceutical Companies Third-Quarter Profits
Pharmaceutical Companies Third-Quarter Profits News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Pharmaceutical Companies Third-Quarter Profits News
- PicksThatMove.com Announces Investment Opinion on Bristol-Myers Squibb Co., Incyte Corp., EnCana Corporation, B2Gold Corp. and 25 Nov 2009 21:36 GMT
... million shares traded. Bristol-Myers : is a biopharmaceutical and related health care products company. Bristol-Myers ... Last company announcement, released mid month, confirmed third quarter financial results with cash flow of ... in any company mentioned herein and may profit in the event those shares rise in ...
- PicksThatMove.com Announces Investment Opinion on Bristol-Myers Squibb Co., Incyte Corp., EnCana Corporation, B2Gold Corp. and Medclean Technologies Inc. 25 Nov 2009 21:33 GMT
... with 24 million shares traded. is a biopharmaceutical and related health care products company. Bristol-Myers ... Last company announcement, released mid month, confirmed third quarter financial results with cash flow of ... in any company mentioned herein and may profit in the event those shares rise in ...
- News and FDA Updates for Radient (NYSE:RPC), Synovis (Nasdaq:SYNO) 25 Nov 2009 21:23 GMT
... be found on BioMedReports.Com On 11/24/09, Radient Pharmaceuticals Corporation (NYSE:RPC), a US-based pharmaceutical company specializes ... Securities and Exchange Commission ("SEC") for fiscal third quarter FY2009. On 11/24/09, Synovis Life Technologies, Inc. ... are not limited to projections of revenues, earnings, segment performance, cash flows, contract awards, FDA ...
- Sanofi Expands REGN Agreement - Analyst Blog 25 Nov 2009 20:15 GMT
... extended and expanded its antibody collaboration with biopharmaceutical company, ). The companies had initially entered ... left by patent expirations. The recently concluded third quarter saw the company entering into licensing and ... contain operating costs in order to grow earnings in the face of weakening sales of ...
- Sanofi Expands Regeneron Agreement - Analyst Blog 25 Nov 2009 20:15 GMT
... extended and expanded its antibody collaboration with biopharmaceutical company, ). The companies had initially entered ... left by patent expirations. The recently concluded third quarter saw the company entering into licensing and ... contain operating costs in order to grow earnings in the face of weakening sales of ...
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 25 25 Nov 2009 19:35 GMT
... (For large-cap stocks on the move, click on) Nov ... profit on lower costs and forecast strong third-quarter earnings. The specialty retailer posted a wider ... was withdrawing its fiscal 2010 forecast. Swiss drugmaker Novartis has struck a licensing deal with ...
- UK Q3 GDP Revised; Compass Group Surges 25 Nov 2009 19:33 GMT
... – UK stocks closed higher after the third quarter GDP estimates was revised to 0.3 ... 0.4% fall. London Stock Exchange Group first-half profit declines. Compass Group shares hit 7-year high ... pence per share a year ago. GW Pharmaceuticals plc the developer and manufacturer of a ...
- FTSE closes higher; miners shine as metals rise 25 Nov 2009 19:16 GMT
... metals prices * Compass Group jumps as profit tops market expectations LONDON, Nov 25 - ... goods tempered some of the optimism. [ID:nN25346193] Pharmaceuticals, seen as resistant to a weak economy, ... Britain's economy shrank 0.3 percent in the third quarter, from a previous reading of 0.4 ...
- FTSE closes higher on miners 25 Nov 2009 18:15 GMT
... manufactured goods tempered some of the optimism. Pharmaceuticals, seen as resistant to a weak economy, ... its recession-proof credentials, posting a 33 percent profit rise which topped market expectations and propelled ... the economy shrank 0.3 percent in the third quarter, from a previous reading of 0.4 ...
- ADR Report-Foreign shares rise after US jobless, housing data 25 Nov 2009 18:12 GMT
... gained 4.6 percent to $7.13 after reporting third-quarter earnings that topped Wall Street's expectations. [ID:nWNAB9562] India's ... of top shares gained 0.5 percent, with pharmaceuticals among the best performers. [ID:nGEE5AO2CO] The Bank ...
- Glance-FTSE closes higher; miners shine as metals rise 25 Nov 2009 18:10 GMT
... manufactured goods tempered some of the optimism. Pharmaceuticals, seen as resistant to a weak economy, ... its recession-proof credentials, posting a 33 percent profit rise which topped market expectations and propelled ... Britain's economy shrank 0.3 percent in the third quarter, from a previous reading of 0.4 ...
- Frutarom's net profit increased by 6.3% - to US$ 10 M 25 Nov 2009 17:37 GMT
... Frutarom's net profit increased by 6.3% - to US$ 10 ... trend of destocking which ended during the third quarter - The company estimates that it ... mainly for the food, beverage, flavor, fragrance, pharmaceutical, nutraceutical, health food, functional food, food additive, ...
- Three Reasons Merck's Time Has Come 25 Nov 2009 15:57 GMT
... I can almost smell the turkey and taste the cranberry ... fine Wednesday morning: Looks like the big-name drug maker is planning on opening up its wallet: ... The apparel retailer was out with its third-quarter numbers, which were pretty good. In the ...
- www.StockMarketingInc.com: Check Us Out!!! Sign Up Now For Our Free Newsletter!! HGSI,AFFX,CNQR,CONN,DMAN,DNDN 25 Nov 2009 14:57 GMT
... technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies, as well as ... as well as leading academic, government and not-for-profit research institutes. More than 1,800 systems have ... loss per share was $0.68 for the third quarter of fiscal 2010, including a $9.6 ...
- Benzinga's News Roundup (TIF, WBD, NVS) 25 Nov 2009 14:52 GMT
... pre-market session. ) today swung to a third quarter profit of $44.5 million as compared to $31 ... trading at $55.86, up 1.01% after Idera Pharmaceuticals today announced that Novartis AG will terminate ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
Healthcare Industry Today
|